HCC Pharm ApS: Financial statements 2025
CVR: 41029013
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
HCC Pharm ApS (CVR 41029013) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 21,630 and a net result of DKK -19,646 compared with DKK 21,488 the year before. That is a decrease of 67% compared with the year before. Equity in the 2025 report amounted to DKK -88,244.
- Gross Profit
- DKK 21,630
- Profit/Loss
- DKK -19,646
- Equity
- DKK -88,244
- Total Assets
- DKK 1,857,510
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 22K | -20K | -88K | 0 |
| 2024 | - | 66K | 21K | -69K | - |
| 2023 | - | 28K | -4K | -90K | 1 |
| 2022 | - | 29K | -13K | -86K | 1 |
| 2021 | - | 18K | -25K | -72K | 1 |
Official annual report
How creditworthy is HCC Pharm ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
HCC Pharm ApS has published its annual report for 2024. Gross profit came to DKK 65,623, and the net result was DKK 21,488.
About HCC Pharm ApS
HCC Pharm ApS is a Danish company of the type Anpartsselskab based in Haarby, founded in 2019. The company is registered under the industry Dyrkning af krydderiplanter, aromaplanter og lægeplanter. The management consists of Hartmuth Hermann Walter Kleiß. The company is owned by Hartmuth Hermann Walter Kleiß. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 21,630 and a net result of DKK -19,646 compared with DKK 21,488 the year before. Equity in the 2025 report amounted to DKK -88,244.